Reference
- Virag R (1982). Intracavernous injection of papaverine for erectile dysfunction. Letter to the editor. Lancet, 2, 938.
- Virag R (1984), Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology, 35, 79/87.
- Zorgniotti AW, Lefleur RS (1988). Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculo-genic impotence. J. Urol., 133, 39–41.
- Carlson LA, Eriksson I (1973). Femoral artery infusion of prostaglandin El in severe peripheral vascular disease. Lancet, Jan 20,155–156.
- Ishii Watanabe H, Irisawa C, et al. (1986). Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin Ei for organic impotence. Nippon Hinyokika Gakkai Kasshi, 77, 954–962 (In Japanese).
- Hamberg A, Samuelson B (1971). On the metabolism of prostaglandins El and B2 in man. J. Biol. Chem., 246, 6713–6721.
- Goldstein I, Borges FD, Fitch WP, Kaufman J, Damron K, Moreno J, Payton T, Yingst J, Krane RJ (1990). Rescuing the failed papa-verine/phentolamine erection: a proposed synergistic action of papaverine, phentol-amine and prostaglandin El. J. Urol., part 2, 143, 304A, abstract 463.
- Lue TF, Goldstein I (1993). Introduction. In: The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction. Goldstein I, Lue TF, eds, Excerpta Medica, Princeton: pp. 1–2.
- Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I (1994). PGE1 suppresses the induction of new collagen synthesis by transforming growth factor beta-1 in human corpus cavernosum smooth muscle: mechanism of penile ischemia associated fibrosis. J. Urol., part 2, 151, 431A, abstract 815.
- Ledda A (1996). Intracavernosal drug therapy. Vascular Andrology, Springer-Verlag, Berlin: pp. 57–62.
- Boolel M, Gepi-Attee S, Gingell JC, Allen MJ. (1996). Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Urol., 78, 257–261.
- Rosen R and Process of Care Consensus Panel (1999). The process of cere model for evaluation and treatment of erectile dys-function. Int. J. Impotence Res., 11, 59–74.